Загрузка...
Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/ https://ncbi.nlm.nih.gov/pubmed/22754787 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|